Overview

This report outlines the key findings and recommendations made by the APPG on Coronavirus. The UK is still experiencing a high number of daily Covid-19 cases, with an average of over 30,000 cases per day. The evidence heard by the APPG makes clear that, while the UK Government should complete the UK's domestic vaccination programme, including offering vaccines to teenagers, there is an urgent need for the UK government to ensure equitable access to Covid-19 vaccines across the world, both now and in the long term. The APPG recommends that the UK government must urgently show global leadership in the effort to vaccinate the world.  Despite the life-saving vaccines in our toolbox, the fight against Covid-19, both in the UK and the rest of the world, cannot be won until vaccines can be accessed equitably in all lower and-middle-income countries. 

The UK government must adopt a sustainable approach by which, in the short term, vaccines are donated from the UK to COVAX through a vaccine matching policy in which for each dose imported to the UK, one dose is donated to COVAX. In the longer term, the government must ensure that capacity for vaccine manufacture is accelerated both abroad, and in the UK.  Additionally, it is essential that the UK government shows support to the WTO TRIPS waiver proposal and technology transfer, enabling vaccine manufacturing capability in low and-middle-income countries to progress. 

To meet demands of expanding the vaccine rollout nationally, it is essential that the UK continues to invest in the research required to ensure that safe and effective vaccines are developed for all ages. 

Overall, the evidence makes clear there is an urgent need to close the global vaccine divide.  Failure to do risks not only the health, but the wealth and security of the both the UK and the world.